Both these names reported third-quarter results last week.
Small-cap stocks are finally making an upside breakout.
These names both offer reasons to think their fortunes could turn as 2020 approaches.
The fact that money is flowing into large-cap stocks rather than small caps suggests there is some underlying weakness in the marketplace.
A pullback now would be very simple, easy and logical, but the market seldom makes it simple, easy or logical.
There are always various trends at work in the stock market and they often have little to do with the movement of the major indices.
Shares of Stemline Therapeutics and Entercom Communications headed opposite directions last Friday after reporting results.
A look at Supernus Pharmaceuticals and TPI Composites provides a tutorial on reaping rewards from stocks the market suddenly hates.
Few investors have likely heard of this Montana-based bank holding company and its attractive yield.
Karyopharm Therapeutics and Pieris Pharmaceuticals are climbing this week on positive news, while Supernus Pharmaceuticals takes a hit.